Printer Friendly

Carrageenan: response. (Correspondence).

It is difficult to recognize a wolf in sheep's clothing. This seems to be the situation with regard to carrageenan.

In response to a letter to EHP from Phil Carthew, I commented on some of the data used for the recent Joint FAO/WHO Expert Committee on Food Additives (JECFA) review to which Kirsch refers (1,2). I found the JECFA conclusions disconcerting in view of the available evidence. Previously, the JECFA considered modification of their recommendation about carrageenan to include a minimum average molecular weight (3,4).

Extensive experimental data have demonstrated that a) degraded carrageenan produces neoplasms and ulcerations in animal models; b) acid hydrolysis, such as occurs in the stomach, leads to the production of degraded carrageenan from food-grade carrageenan; and c) food-grade carrageenan contains significant amounts of degraded carrageenan. Human consumption of carrageenan has been increasing steadily in the United States in the 20th century (5-8).

The data with regard to intestinal effects of carrageenan seem sufficient to mandate restriction of carrageenan intake. I remain hopeful that the Food and Drug Administration and the JECFA will revise their recommendations pertaining to the safe use of carrageenan, that industry will substitute other gums for carrageenan, that red seaweed farmers will diversify, and that consumers will select food products without carrageenan.

REFERENCES AND NOTES

(1.) Carthew P. Safety of carrageenan in foods [Letter]. Environ Health Perspect 110:A176 (2002).

(2.) Tobacman, JK. Carrageenan in foods: response [Letter]. Environ Health Perspect 110:A176 (2002).

(3.) Greig JB. Carrageenan. WHO Safety Evaluation of Certain Food Additives. Food Additives Series 42. Geneva:World Health Organization, 1999. Available: http://www.inchem.org/documents/jecfa/jecmono/ v042je08.htm [cited 9 April 2002].

(4.) European Commission. Draft Commission Directive. III/5343/96 EN Brussels:European Commission, 1996.

(5.) Tobacman JK. Review of harmful gastrointestinal effects of carrageenan in animal experiments. Environ Health Perspect 109:983-994 (2001).

(6.) Yu G, Guan H, Ioanoviciu AS, Sikkander SA, Thanawiroon C, Tobacman JK, Toida T, Linhardt RJ. Structural studies on [kappa]-carrageenan derived oligosaccharides. Carbohydr Res 337:433-440 (2002).

(7.) Marrs WM. The stability of carrageenans to processing. In: Gums and Stabilisers for the Food Industry 9 (Williams PA, Phillips GO, eds). Cambridge, UK:The Royal Society of Chemistry, 1998;345-357.

(8.) Capron I, Yvon M, Muller G. In-vitro gastric stability of carrageenan. Food Hydrocoll 10(2):239-244 (1996).
Joanne Tobacman
University of Iowa Health Care
Iowa City, Iowa
E-mail: joanne-tobacman@uiowa.edu
COPYRIGHT 2002 National Institute of Environmental Health Sciences
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2002, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 
Article Details
Printer friendly Cite/link Email Feedback
Author:Tobacman, Joanne
Publication:Environmental Health Perspectives
Date:Jun 1, 2002
Words:405
Previous Article:Carrageenan: a safe additive. (Correspondence).
Next Article:Public fear of dioxins from modern municipal waste incinerators is not justified. (Correspondence).


Related Articles
Nonfat dry milk boosts quality of cooked deli poultry.
Study safety of widely used additive.
Review of harmful gastrointestinal effects of carrageenan in animal experiments. (Research Review).
Safety of carrageenan in foods. (Correspondence).
Carrageenan in foods: response. (Correspondence).
Carrageenan: a safe additive. (Correspondence).
Examine hydrocolloid functionality in frozen, refrigerated foods.
Nutrition hotline.
Ingredient might prevent sexually transmitted disease.

Terms of use | Privacy policy | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters